CellAlzheimer DiseaseHumanstau ProteinsAmyloid beta-PeptidesImmunotherapy
The evolving landscape of Alzheimer's disease therapy: From Aβ to tau.
Jean-Philippe Courade, Henrik Zetterberg, Günter U Höglinger, Ilse Dewachter
Published: 202510.1016/j.cell.2025.11.033
Abstract
A marked evolution in Alzheimer's disease (AD) therapy research is ongoing. In this perspective, we highlight emerging outcomes of tau-targeting approaches with disease-modifying potential evidenced by PET-based slowing of tau accumulation and early…
Preview only. Read the full abstract at the source